Publication

M-27: Guideline for Complying with Data Integrity Regulatory Expectations

Abstract

Both the U.S. Food and Drug Administration (FDA) and Health Canada (HC) have developed guidance documents for their respective current expectations for data integrity to comply with respective Current Good Manufacturing Practices (CGMP) requirements. In the United States, see Data Integrity and Compliance with CGMP Guidance for Industry and in Canada, see Health Canada Guidance Document GUI-0001, Good manufacturing practices guide for drug products.

This publication provides guidance and acceptable practices for the medical gas industry to comply with data integrity. It identifies the acquisition and retention of data obtained to assure it is complete, consistent, accurate, attributable, contemporaneously recorded, and auditable regardless of the form in which it is obtained and maintained.

This publication does not address what data is acquired during the manufacturing and testing of medical gases.

Access Publication

Member Price:
$15
Subscriber Price:
$15
Non-Member Price:
$27

Member E-Pub Price:
$0
Subscriber E-Pub Price:
$0
Non-Member E-Pub Price:
$27
Buy Hard Copy
Purchase E-Pub
View Table of Contents (free)

Properties

Edition:
1
Published:
August 2021
Status:
Available To the Public
Size:
5 pages
Publisher:
CGA
Special Attributes:
Notes:
Committee:

Cataloging

Category
Medical Gases     Standards & Guidelines
Keywords
medical gases
Related
M-16